20:12 EST Cathie Wood’s ARK Investment buys 223.5K shares of Intellia Therapeutics (NTLA) today
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTLA:
- Intellia Therapeutics Announces Promising CRISPR Therapy Results
- Intellia Therapeutics price target lowered to $70 from $80 at Wells Fargo
- Intellia Therapeutics price target raised to $91 from $88 at Chardan
- Intellia Therapeutics price target lowered to $60 from $70 at Oppenheimer
- Intellia Therapeutics price target lowered to $55 from $76 at Barclays